Table 3.
GerdQ scores by country and treatment group
| Treatment group* | ||
|---|---|---|
| Control | Implementation | |
| Austria | ||
| Number of patients | 308 | 277 |
| Baseline | 6.83 (2.77) | 7.44 (2.68) |
| Follow-up | 2.56 (2.30) | 2.12 (1.84) |
| Change (follow-up – baseline) | −4.28 (2.96) | −5.32 (3.19) |
| Italy | ||
| Number of patients | 171 | 164 |
| Baseline | 6.36 (3.02) | 5.70 (2.49) |
| Follow-up | 2.94 (2.82) | 1.51 (1.93) |
| Change (follow-up – baseline) | −3.42 (3.44) | −4.19 (2.98) |
| Norway | ||
| Number of patients | 165 | 170 |
| Baseline | 5.91 (2.86) | 6.21 (2.64) |
| Follow-up | 1.81 (2.35) | 1.50 (2.09) |
| Change (follow-up – baseline) | −4.10 (3.20) | −4.71 (3.24) |
| Spain | ||
| Number of patients | 128 | 153 |
| Baseline | 6.09 (2.94) | 6.88 (2.51) |
| Follow-up | 2.63 (2.47) | 1.76 (2.39) |
| Change (follow-up – baseline) | −3.47 (3.33) | −5.12 (3.13) |
| Sweden | ||
| Number of patients | 128 | 70 |
| Baseline | 5.16 (2.98) | 6.73 (2.55) |
| Follow-up | 3.27 (2.87) | 1.89 (2.37) |
| Change (follow-up – baseline) | −1.89 (3.33) | −4.84 (3.26) |
| Overall | ||
| Number of patients | 900 | 834 |
| Baseline | 6.23 (2.94) | 6.68 (2.67) |
| Follow-up | 2.60 (2.56) | 1.79 (2.08) |
| Change (follow-up – baseline) | −3.63 (3.30) | −4.90 (3.17) |
Values are means (SD).
*
Control = usual care; implementation = structured treatment pathway. GerdQ, Gastro-oesophageal Reflux Disease Questionnaire.